Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

AI Chatbots Are Replacing Therapists — With Almost No Science to Back Them Up

by Team Lumida
June 30, 2026
in AI
Reading Time: 3 mins read
A A
0
AI Investment Boom: How Tech Giants Are Leading the Charge

"Machine Learning & Artificial Intelligence" by mikemacmarketing is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Over 100 mental-health-focused AI chatbots have entered the market, but a 2025 Stanford study found therapy-specific bots performed worse than general-purpose AI at basic safety benchmarks — including failing to catch subtle suicidal ideation, with one bot providing bridge heights in meters when a user mentioned losing their job and asked about tall NYC bridges.
  • Major platforms are racing to launch AI therapy products: Talkspace debuted “Tee,” trained on real therapist-client text messages; Headspace launched “Ebb” with a built-in 30-minute session cap to prevent dependency; Lyra Health restricts chatbot access to users already in concurrent human therapy.
  • The Centers for Medicare and Medicaid Innovation is set to pilot reimbursement for AI mental-health chatbots in July, tying modest payments to health outcomes — creating federal legitimacy for the sector before rigorous safety evidence exists.
  • Mental-health professionals warn the bots are engineered to be helpful and agreeable — exactly the wrong trait for therapy, where pushing back on patients is often essential — and they can’t read facial expressions, tears, or the nonverbal cues that underpin the therapeutic relationship.

What Happened?

The mental-health AI chatbot market has grown to over 100 products, with companies like Talkspace (Tee), Headspace (Ebb), and Lyra Health racing to offer AI companions positioned as supplements — or outright replacements — to traditional therapy. A 2025 Stanford study found that therapy-focused chatbots performed worse than general-purpose models at safety and appropriateness benchmarks; one bot provided bridge heights in meters to a user expressing subtle suicidal ideation by asking about tall NYC bridges after mentioning job loss. Talkspace says Tee was trained specifically to catch such signals, including the exact Stanford bridge scenario. Meanwhile, the Centers for Medicare and Medicaid Innovation is set to begin paying providers for AI mental health services in July, tied to health outcomes — the first federal reimbursement framework for the sector.

Why It Matters?

The US mental health system is structurally broken: more than a third of psychologists don’t accept insurance, and nearly half report no available patient openings, according to the American Psychological Association. That scarcity is driving patients toward AI alternatives that are cheaper, always available, and require no referral. But therapists and researchers warn that the very traits that make AI appealing — helpfulness and agreeableness — are exactly wrong for mental healthcare, where effective treatment often requires challenging a patient’s distorted thinking. The FDA has not regulated any of these tools, and mass adoption is accelerating well ahead of clinical evidence and government oversight.

What’s Next?

Several states have already enacted laws regulating AI mental health chatbots, citing dependency risks and inadequate guardrails. The APA’s senior director of healthcare innovation is calling for federal oversight of tools that may effectively be providing therapy without a license. The CMS pilot launching in July will be the critical test case: if reimbursement normalizes AI therapy before evidence requirements are established, adoption could accelerate far ahead of the safety science. For now, the industry occupies a regulatory no-man’s-land — no longer just wellness apps, but not yet medical devices either.

Source: The Wall Street Journal

Previous Post

Saylor Breaks His Own Rule: Strategy to Sell Bitcoin and Buy Back Shares to Survive Crypto Winter

Next Post

Hormuz Traffic Rebounds as Supertankers Return to Persian Gulf After Ceasefire

Recommended For You

California Attorney General Rob Bonta Issues a Subpoena to Nvidia Over Whether Advanced Chips Reached China and Investors Were Misled

by Team Lumida
1 day ago

California AG Rob Bonta issued an investigative subpoena to Nvidia on Thursday over whether advanced chips reached China and whether investors were misled.

Read more

U.S. Approved Nearly 880,000 AI Chip Sales to Chinese Firms Including Tencent and Alibaba, House Data Show

by Team Lumida
1 day ago

House data show the U.S. approved nearly 880,000 AI chip sales to China, including shipments for Tencent and Alibaba, after Nvidia and AMD sought 3.4 million.

Read more

Anthropic Closes at $88.91, Down 8.5% on Its Second Day, After a Debut High Above $115, as the IPO Fails to Revive the AI Trade

by Team Lumida
1 day ago

Anthropic fell 8.5% to $88.91 on its second session, giving back much of Thursday’s 17% debut gain, as valuation anxiety kept the AI trade under pressure.

Read more

Trump Says the US Could Let Nvidia Sell Blackwell Chips to China in ‘Two Years or Three Years,’ Calling the H200 ‘Semi-Obsolete’ as Congress Moves to Bar Sales for 18 Months

by Team Lumida
3 days ago

Trump said Nvidia could sell Blackwell chips to China in two or three years, as senators push the AI Overwatch Act to bar such sales for at least...

Read more

Intel Signs Its First Outside Customer for 18A Chips and Names Microsoft as Its First Public Customer for EMIB Packaging, After Losing More Than Half Its Value Since September

by Team Lumida
3 days ago
Intel Surges 5%, SK Hynix Up 3% on Reports of U.S. Memory Chip Manufacturing Deal to Serve Nvidia and AI Demand

Intel CEO Lip-Bu Tan said the company signed its first outside customer for 18A chips and named Microsoft as its first public EMIB packaging customer.

Read more

China’s Military Is ‘Actively Soliciting’ Nvidia’s Most Advanced Chips for AI-Enabled Military Capabilities, a Congressional Commission Says in Its 2026 Report

by Team Lumida
3 days ago

A congressional commission said China’s military is seeking advanced Nvidia chips and evading export controls, including via data centers in Malaysia.

Read more

Bipartisan Push to Attach AI Chip Export Limits to the December NDAA Gains Steam After the Huang Affair, With Schumer, Jeffries and Speaker Johnson Backing the AI Overwatch, MATCH and Chip Security Acts

by Team Lumida
4 days ago

Lawmakers from both parties are pushing three chip export bills into the December defense bill after Jensen Huang’s resignation, but time is short.

Read more

Banks Pause a $480 Million Nvidia GPU Loan to Aolani Cloud Tied to ByteDance After New US Licensing Rules for Malaysia and Singapore Data Centers

by Team Lumida
4 days ago
ByteDance Is Buying Custom Chips From Taiwan Because It Cannot Buy Nvidia’s, Which US Rules Permit

Banks paused or reconsidered a $480 million Aolani Cloud loan for Nvidia GPUs tied to ByteDance after new US licensing rules, Bloomberg reported.

Read more

Commerce and Justice Say They Began Investigating Nvidia Partner Megaspeed in 2024, as Critics Ask Why It Kept Getting Chips After Nvidia’s ‘No Sell’ Listing

by Team Lumida
5 days ago

Commerce and Justice said they opened export-control probes into Megaspeed in 2024 and inspected it in June 2025, as critics question how it kept buying chips.

Read more

Nvidia Warns Chip Buyers That the Remote Access Security Act Could Expose Them to US ‘Legal Action’ and Caps Sales to Clouds Renting Over 50% of GPUs to Chinese Firms

by Team Lumida
5 days ago

Nvidia cautioned customers that the proposed Remote Access Security Act could bring US legal action over Chinese cloud access to its chips, CNBC reported.

Read more
Next Post
Iran’s Island Fortress: The Five Strategic Positions Holding Hormuz Hostage

Hormuz Traffic Rebounds as Supertankers Return to Persian Gulf After Ceasefire

Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic's Mythos Found 10,000 Software Flaws — and That's Exactly Why the Government Shut It Down

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Google’s Bold AI Bet: Transforming Healthcare After Costly Missteps

Google Ordered to Pay Nearly $2 Billion to Klarna’s Pricerunner in Shopping Antitrust Ruling

July 1, 2026

Securitize Buys River One to Enter the $6 Trillion Asset-Backed Finance Market and Unveils a $50 Million Buyback as Revenue Rises 13% to $18.6 Million

November 10, 2026
Consensys Cleared: SEC Drops Investigation, Crypto Market Reacts

Consensys Cleared: SEC Drops Investigation, Crypto Market Reacts

June 19, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018